Comparing early signs and basic symptoms as methods for predicting psychotic relapse in clinical practice

Emily Eisner, Richard Drake, Fiona Lobban, Sandra Bucci, Richard Emsley, Christine Barrowclough, Emily Eisner, Richard Drake, Fiona Lobban, Sandra Bucci, Richard Emsley, Christine Barrowclough

Abstract

Background: Early signs interventions show promise but could be further developed. A recent review suggested that 'basic symptoms' should be added to conventional early signs to improve relapse prediction. This study builds on preliminary evidence that basic symptoms predict relapse and aimed to: 1. examine which phenomena participants report prior to relapse and how they describe them; 2. determine the best way of identifying pre-relapse basic symptoms; 3. assess current practice by comparing self- and casenote-reported pre-relapse experiences.

Methods: Participants with non-affective psychosis were recruited from UK mental health services. In-depth interviews (n=23), verbal checklists of basic symptoms (n=23) and casenote extracts (n=208) were analysed using directed content analysis and non-parametric statistical tests.

Results: Three-quarters of interviewees reported basic symptoms and all reported conventional early signs and 'other' pre-relapse experiences. Interviewees provided rich descriptions of basic symptoms. Verbal checklist interviews asking specifically about basic symptoms identified these experiences more readily than open questions during in-depth interviews. Only 5% of casenotes recorded basic symptoms; interviewees were 16 times more likely to report basic symptoms than their casenotes did.

Conclusions: The majority of interviewees self-reported pre-relapse basic symptoms when asked specifically about these experiences but very few casenotes reported these symptoms. Basic symptoms may be potent predictors of relapse that clinicians miss. A self-report measure would aid monitoring of basic symptoms in routine clinical practice and would facilitate a prospective investigation comparing basic symptoms and conventional early signs as predictors of relapse.

Keywords: Basic symptoms; Early signs; Psychosis; Relapse; Schizophrenia.

Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Figures

Fig. 1
Fig. 1
Number of basic symptoms, early signs and ‘other’ experiences reported pre-relapse in the in-depth interview or verbal checklist (n = 23), ranked by basic symptoms.
Fig. 2
Fig. 2
A descriptive ROC curve exploring the predictive value of different basic symptom criteria (data labels indicate threshold number of basic symptoms used to estimate sensitivity and specificity figures).

References

    1. Almond S., Knapp M., Francois C., Toumi M., Traolach B. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br. J. Psychiatry. 2004;184:346–351.
    1. Andrew A., Knapp M., McCrone P., Parsonage M., Trachtenberg M. Rethink Mental Illness; London: 2012. Effective Interventions in Schizophrenia the Economic Case: A Report Prepared for the Schizophrenia Commission.
    1. APA . fourth ed. American Psychiatric Association; Washington, DC: 2000. Diagnostic and Statistical Manual of Mental Disorders.
    1. Appleby L. Suicide in psychiatric patients: risk and prevention. Br. J. Psychiatry. 1992;161(6):749–758.
    1. Bechdolf A., Schultze-Lutter F., Klosterkötter J. Self-experienced vulnerability, prodromal symptoms and coping strategies preceding schizophrenic and depressive relapses. Eur. Psychiatry. 2002;17:384–393.
    1. Birchwood M., Smith J., Macmillan F., Hogg B., Prasad R., Harvey C., Bering S. Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation. Psychol. Med. 1989;19(3):649–656.
    1. BMA . British Medical Association; 2014. Requests for Disclosure of Data for Secondary Purposes.
    1. Eisner E., Drake R., Barrowclough C. Assessing early signs of relapse in psychosis: review and future directions. Clin. Psychol. Rev. 2013;33(5):637–653.
    1. Fusar-Poli P., Bonoldi I., Yung A.R., Borgwardt S., Kempton M.J., Valmaggia L., Barale F., Caverzasi E., McGuire P. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch. Gen. Psychiatry. 2012;69(3):220–229.
    1. Gaebel W., Riesbeck M. Are there clinically useful predictors and early warning signs for pending relapse? Schizophr. Res. 2014;152(2–3):469–477.
    1. Gumley A., Schwannauer M. John Wiley and Sons; Chichester: 2006. Staying Well after Psychosis: A Cognitive Interpersonal Approach to Recovery and Relapse Prevention.
    1. Gumley A., O'Grady M., McNay L., Reilly J., Power K., Norrie J. Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol. Med. 2003;33(3):419–431.
    1. Gumley A.I., MacBeth A., Reilly J.D., O'Grady M., White R.G., McLeod H., Schwannauer M., Power K.G. Fear of recurrence: results of a randomized trial of relapse detection in schizophrenia. Br. J. Clin. Psychol. 2015;54(1):49–62.
    1. Herz M., Lamberti J., Mintz J., Scott R., O'Dell S., McCartan L., Nix G. A program for relapse prevention in schizophrenia: a controlled study. Arch. Gen. Psychiatry. 2000;57(3):277–283.
    1. Hsieh H.F., Shannon S.E. Three approaches to qualitative content analysis. Qual. Health Res. 2005;15(9):1277–1288.
    1. Johnson C. University of Manchester; Manchester: 2013. Clinical Predictors in Young Help-Seeking People Referred to the Lancashire Early Assessment and Detection Clinic: A Service Evaluation.
    1. Lee S.H., Choi T.K., Suh S., Kim Y.W., Kim B., Lee E., Yook K.H. Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection. Psychiatry Res. 2010;175(3):195–199.
    1. Libby L.A., Yonelinas A.P., Ranganath C., Ragland J.D. Recollection and familiarity in schizophrenia: a quantitative review. Biol. Psychiatry. 2013;73(10):944–950.
    1. Maclean C. University of Glasgow; Glasgow: 2008. An Interpretative Phenomenological Analysis of Service Users' Perspectives and Experiences of Relapse in Psychosis.
    1. Robinson D., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., Lieberman J.A. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry. 1999;56(3):241–247.
    1. Schultze-Lutter F., Addington J., Ruhrmann S., Klosterkötter J. Giovanni Fioriti Editore; Rome, Italy: 2007. Schizophrenia Proneness Instrument: Adult Version (SPI-A)
    1. Speer J.R., Flavell J.H. Young childrens knowledge of the relative difficulty of recognition and recall memory tasks. Dev. Psychol. 1979;15(2):214–217.
    1. WHO . World Health Organisation; Geneva: 1992. ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines.
    1. Wiersma D., Nienhuis F., Slooff C., Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr. Bull. 1998;24(1):75–85.
    1. Wu E.Q., Birnbaum H.G., Shi L., Ball D.E., Kessler R.C., Moulis M., Aggarwal J. The economic burden of schizophrenia in the United States in 2002. J. Clin. Psychiatry. 2005;66(9):1122–1129.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit